Ameriprise Financial Inc Mirati Therapeutics, Inc. Transaction History

Ameriprise Financial Inc

$381 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$41.99 - $62.38 $251 - $374	-6 Reduced 0.08%	7,371 $433,000
Q3 2023 Nov 14, 2023	BUY	$27.8 - $45.35 $205,080 - $334,546	7,377 New	7,377 $321,000
Q4 2022 Feb 14, 2023	SELL	$41.27 - $98.62 $34.4 Million - $82.1 Million	-832,704 Reduced 56.65%	637,130 $28.9 Million
Q3 2022 Nov 14, 2022	BUY	$59.5 - $86.7 $466,956 - $680,421	7,848 Added 0.54%	1,469,834 $103 Million
Q2 2022 Aug 15, 2022	SELL	$39.16 - $88.71 $644,847 - $1.46 Million	-16,467 Reduced 1.11%	1,461,986 $98.2 Million
Q1 2022 May 16, 2022	BUY	$75.82 - $150.97 $443,319 - $882,721	5,847 Added 0.4%	1,478,453 $122 Million
Q4 2021 Feb 14, 2022	SELL	$132.01 - $190.29 $14.8 Million - $21.4 Million	-112,393 Reduced 7.09%	1,472,606 $216 Million
Q3 2021 Nov 15, 2021	BUY	$132.13 - $177.45 $154 Million - $207 Million	1,167,647 Added 279.78%	1,584,999 $280 Million
Q2 2021 Aug 16, 2021	BUY	$144.0 - $179.73 $16.5 Million - $20.6 Million	114,710 Added 37.9%	417,352 $67.4 Million
Q1 2021 May 17, 2021	SELL	$158.92 - $221.61 $418,595 - $583,720	-2,634 Reduced 0.86%	302,642 $51.8 Million
Q4 2020 Feb 12, 2021	SELL	$162.05 - $240.27 $24 Million - $35.6 Million	-148,161 Reduced 32.68%	305,276 $67.1 Million
Q3 2020 Nov 16, 2020	SELL	$113.26 - $167.27 $5.17 Million - $7.64 Million	-45,670 Reduced 9.15%	453,437 $75.3 Million
Q2 2020 Aug 14, 2020	BUY	$72.01 - $120.39 $23.5 Million - $39.3 Million	326,275 Added 188.78%	499,107 $57 Million
Q1 2020 May 15, 2020	BUY	$69.78 - $116.21 $5.74 Million - $9.55 Million	82,208 Added 90.71%	172,832 $13.3 Million
Q4 2019 Feb 14, 2020	SELL	$70.76 - $128.86 $2.32 Million - $4.23 Million	-32,820 Reduced 26.59%	90,624 $11.7 Million
Q3 2019 Nov 14, 2019	SELL	$77.91 - $109.6 $1.88 Million - $2.64 Million	-24,123 Reduced 16.35%	123,444 $9.61 Million
Q2 2019 Aug 14, 2019	SELL	$59.49 - $104.71 $319,461 - $562,292	-5,370 Reduced 3.51%	147,567 $15.2 Million
Q1 2019 May 15, 2019	SELL	$43.65 - $78.95 $2.28 Million - $4.13 Million	-52,345 Reduced 25.5%	152,937 $11.2 Million
Q4 2018 Feb 14, 2019	BUY	$32.0 - $47.43 $2.14 Million - $3.18 Million	66,953 Added 48.4%	205,282 $8.7 Million
Q3 2018 Nov 14, 2018	BUY	$47.1 - $62.7 $5.19 Million - $6.92 Million	110,296 Added 393.45%	138,329 $6.54 Million
Q2 2018 Aug 14, 2018	BUY	$26.05 - $52.4 $441,026 - $887,132	16,930 Added 152.48%	28,033 $1.38 Million
Q1 2018 May 15, 2018	SELL	$17.2 - $34.95 $130,290 - $264,746	-7,575 Reduced 40.56%	11,103 $341,000
Q4 2017 Feb 12, 2018	BUY	$12.65 - $19.0 $236,276 - $354,882	18,678	18,678 $341,000

Others Institutions Holding MRTX

# of Institutions

Shares Held

3.57M

Call Options Held

Put Options Held

36.6K

View Full List

About Mirati Therapeutics, Inc.

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

More about MRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account